In ways we never imagined, artificial intelligence is revolutionizing the biotechnology sector. My research delves into the ways AI is changing biotechnology, specifically in immunology, and considers how it might further transform the discipline. I have witnessed how AI is incorporated into routine lab work through my biotechnology lab classes. AI-powered devices, such as automated DNA sequencers and flow cytometers, can handle enormous volumes of data much more quickly than humans could by streamlining procedures and minimizing human error. I saw firsthand how AI is being applied to address pressing issues in healthcare during my internship in immunology. AI models, for instance, can forecast a patient’s immune system’s reaction to specific treatments, enabling researchers to tailor treatments and enhance results. By analyzing immune responses far more quickly than conventional techniques, these tools also speed up the development of vaccines. I became aware that AI is more than just a tool after witnessing this in action; it is now a major force in the battle against illness. I’ve looked into the application of AI in biotech fields other than immunology, such as genetic engineering and drug discovery. AI is now able to predict protein folding, create novel drug molecules, and even improve CRISPR gene-editing methods. But things aren’t always easy. For these technologies to realize their full potential, issues like data privacy, algorithm transparency, and the moral application of AI in healthcare must be resolved. I think AI has the potential to advance biotech even further in the future; some examples include more effective genome editing, personalized medicine at a whole new level, and real-time data analysis in clinical trials. We can advance biotechnology and, eventually, enhance people’s lives globally by comprehending and embracing AI.
December 28, 2025